424 related articles for article (PubMed ID: 24354994)
1. Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation.
Siripongsakun S; Wei SH; Lin S; Chen J; Raman SS; Sayre J; Tong MJ; Lu DS
J Gastroenterol Hepatol; 2014 Jan; 29(1):157-64. PubMed ID: 24354994
[TBL] [Abstract][Full Text] [Related]
2. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.
Tateishi R; Shiina S; Yoshida H; Teratani T; Obi S; Yamashiki N; Yoshida H; Akamatsu M; Kawabe T; Omata M
Hepatology; 2006 Dec; 44(6):1518-27. PubMed ID: 17133456
[TBL] [Abstract][Full Text] [Related]
3. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
5. A combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma.
Ertle JM; Heider D; Wichert M; Keller B; Kueper R; Hilgard P; Gerken G; Schlaak JF
Digestion; 2013; 87(2):121-31. PubMed ID: 23406785
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z
Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626
[TBL] [Abstract][Full Text] [Related]
7. Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein.
Nouso K; Kobayashi Y; Nakamura S; Kobayashi S; Takayama H; Toshimori J; Kuwaki K; Hagihara H; Onishi H; Miyake Y; Ikeda F; Shiraha H; Takaki A; Iwasaki Y; Kobashi H; Yamamoto K
J Gastroenterol Hepatol; 2011 Jul; 26(7):1195-200. PubMed ID: 21410750
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
[TBL] [Abstract][Full Text] [Related]
9. α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C.
Asahina Y; Tsuchiya K; Nishimura T; Muraoka M; Suzuki Y; Tamaki N; Yasui Y; Hosokawa T; Ueda K; Nakanishi H; Itakura J; Takahashi Y; Kurosaki M; Enomoto N; Nakagawa M; Kakinuma S; Watanabe M; Izumi N
Hepatology; 2013 Oct; 58(4):1253-62. PubMed ID: 23564522
[TBL] [Abstract][Full Text] [Related]
10. Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.
Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Wu JC; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD
Clin Radiol; 2012 May; 67(5):429-36. PubMed ID: 22153231
[TBL] [Abstract][Full Text] [Related]
11. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
Lao OB; Weissman J; Perkins JD
Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644
[TBL] [Abstract][Full Text] [Related]
12. Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis.
Shim JH; Yoon DL; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
Ann Surg Oncol; 2012 Nov; 19(12):3687-96. PubMed ID: 22644512
[TBL] [Abstract][Full Text] [Related]
13. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of alpha-fetoprotein in chronic hepatitis C.
Tai WC; Hu TH; Wang JH; Hung CH; Lu SN; Changchien CS; Lee CM
J Formos Med Assoc; 2009 Mar; 108(3):210-8. PubMed ID: 19293036
[TBL] [Abstract][Full Text] [Related]
15. Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.
Sterling RK; Jeffers L; Gordon F; Venook AP; Reddy KR; Satomura S; Kanke F; Schwartz ME; Sherman M
Clin Gastroenterol Hepatol; 2009 Jan; 7(1):104-13. PubMed ID: 18849011
[TBL] [Abstract][Full Text] [Related]
16. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
Jeng KS; Sheen IS; Tsai YC
Am J Gastroenterol; 2004 Aug; 99(8):1503-9. PubMed ID: 15307868
[TBL] [Abstract][Full Text] [Related]
17. [Impact of serum α-fetoprotein level on short-term recurrence after R0 resection in primary hepatocellular carcinoma].
Li SP; Wu LQ
Zhonghua Wai Ke Za Zhi; 2013 Jul; 51(7):600-3. PubMed ID: 24256584
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
[TBL] [Abstract][Full Text] [Related]
19. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
[TBL] [Abstract][Full Text] [Related]
20. Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.
Kim YI; Kim HS; Park JW
PLoS One; 2016; 11(6):e0157299. PubMed ID: 27304617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]